April 7, 2020

April 06, 2020

Subscribe to Latest Legal News and Analysis

April 05, 2020

Subscribe to Latest Legal News and Analysis

Examining the Impact of the Supreme Court's Limelight v. Akamai Decision [VIDEO]

Gaby L. Longsworth, Ph.D. discusses the recent U.S. Supreme Court decision in Limelight Networks, Inc. v. Akamai Technologies, Inc. She explains the patent issue at hand, outlines the Supreme Court's ruling, and provides more detail on the potential impact of the decision, particularly for pharmaceutical and medical diagnostic companies

© 2020 Sterne Kessler


About this Author

Gaby L. Longsworth, PhD. Biotechnology Chemical Attorney Sterne Kessler law firm

Gaby L. Longsworth, Ph.D., is a Director in the Biotechnology/Chemical Group.   Dr. Longsworth is sought out by both innovator and generic pharmaceutical companies for her insights and knowledge of intellectual property and brand product lifecycle management strategies.

A large part of Dr. Longsworth's practice is focused on representing international and domestic generic pharmaceutical companies in patent cases involving Abbreviated New Drug Applications (ANDAs) that include a Paragraph IV (pIV) certification to one or more Orange Book listed patents.  She has been involved in...